Cyclin-dependent kinase 1 expression is inhibited by p16 INK4a at the post-transcriptional level through the microRNA pathway

Oncogene

Volumn 30, Issue 16, 2011, Pages 1880-1891

  Chien, W W ^a   Domenech, C ^a   Catallo, R ^a   Kaddar, T ^a   Magaud, J P ^a,b   Salles, G ^a,c   Ffrench, M ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

CDK1; cell cycle; E2F; microRNA; post transcriptional regulation

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN E; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 410; MICRORNA 650; PROTEIN P107; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F4; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GLIOBLASTOMA; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA DEGRADATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; WILD TYPE;

EID: 79955466833     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.570     Document Type: Article

References (52)

1. Alevizopoulos K, Vlach J, Hennecke S, Amati B. (1997). Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. Embo J 16: 5322-5333. (Pubitemid 27380140)
2. Baghdassarian N, Catallo R, Mahly MA, Ffrench P, Chizat F, Bryon PA et al. (1998). Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins. Exp Cell Res 240: 263-273. (Pubitemid 28371107)
3. Baghdassarian N, Peiretti A, Devaux E, Bryon PA, Ffrench M. (1999). Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes. Cell Growth Differ 10: 405-412. (Pubitemid 29284182)
4. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. (2003). Cdk2 knockout mice are viable. Curr Biol 13: 1775-1785. (Pubitemid 37274109)
5. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A et al. (1995). Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11: 210-212.
6. Calbo J, Serna C, Garriga J, Grana X, Mazo A. (2004). The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity. Cell Death Differ 11: 1055-1065. (Pubitemid 39341631)
7. Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK et al. (2008). Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112: 822-829.
8. Chien WW, Domenech C, Catallo R, Salles G, Ffrench M. (2010). S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53. Cell Cycle 9: 3286-3296.
9. Choi BY, Choi HS, Ko K, Cho YY, Zhu F, Kang BS et al. (2005). The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nat Struct Mol Biol 12: 699-707. (Pubitemid 43086276)
10. Cox CV, Martin HM, Kearns PR, Virgo P, Evely RS, Blair A. (2007). Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood 109: 674-682. (Pubitemid 46105969)
11. Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R et al. (2010). miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140: 652-665.
12. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP et al. (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821. (Pubitemid 41814382)
13. Haas K, Staller P, Geisen C, Bartek J, Eilers M, Moroy T. (1997). Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene 15: 179-192. (Pubitemid 27344557)
14. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. (1996). Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867.
15. Harada H, Nakagawa K, Iwata S, Saito M, Kumon Y, Sakaki S et al. (1999). Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Cancer Res 59: 3783-3789. (Pubitemid 29381887)
16. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134. (Pubitemid 47014436)
17. Hutvagner G, Zamore PD. (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060.
18. Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G et al. (2009). Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol Cell 101: 511-524.
19. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W et al. (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet, Vol 8: pp 23-26.
20. Kataoka M, Wiehle S, Spitz F, Schumacher G, Roth JA, Cristiano RJ. (2000). Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells. Oncogene 19: 1589-1595. (Pubitemid 30175681)
21. Katsuda K, Kataoka M, Uno F, Murakami T, Kondo T, Roth JA et al. (2002). Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene 21: 2108-2113. (Pubitemid 34270900)
22. Kopper L, Hajdu M. (2004). Tumor stem cells. Pathol Oncol Res 10: 69-73. (Pubitemid 38915597)
23. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E et al. (2004). Mouse development and cell proliferation in the absence of D-cyclins. Cell 118: 477-491. (Pubitemid 39485667)
24. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858. (Pubitemid 33032103)
25. Leclerc GJ, Leclerc GM, Barredo JC. (2002). Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines. Cancer Cell Int 2: 1.
26. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. (2005). MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7: 719-723. (Pubitemid 40975754)
27. 0 UTR. Proc Natl Acad Sci USA 104: 9667-9672. (Pubitemid 47175324)
28. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S et al. (2004). Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493-504. (Pubitemid 39485668)
29. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962-967. (Pubitemid 37376927)
30. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishna-murthy J et al. (2006). Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443: 448-452. (Pubitemid 44477280)
31. Moser JJ, Eystathioy T, Chan EK, Fritzler MJ. (2007). Markers of mRNA stabilization and degradation, and RNAi within astro-cytoma GW bodies. J Neurosci Res 85: 3619-3631. (Pubitemid 350228707)
32. Nalabothula N, Lakka SS, Dinh DH, Gujrati M, Olivero WC, Rao JS. (2007). Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death. Int J Oncol 30: 669-678.
33. Nishiwaki E, Turner SL, Harju S, Miyazaki S, Kashiwagi M, Koh J et al. (2000). Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation. Mol Cell Biol 20: 7726-7734.
34. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843. (Pubitemid 40839736)
35. Pillai RS, Bhattacharyya SN, Filipowicz W. (2007). Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17: 118-126. (Pubitemid 46357525)
36. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743. (Pubitemid 46856247)
37. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res 14: 1902-1910. (Pubitemid 39386503)
38. Saetrom P, Heale BS, Snove Jr O, Aagaard L, Alluin J, Rossi JJ. (2007). Distance constraints between microRNA target sites dictate efficacy and cooperativity. Nucleic Acids Res 35: 2333-2342. (Pubitemid 47073716)
39. Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy C, Newton K et al. (2007). Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448: 811-815. (Pubitemid 47266342)
40. Serrano M, Gomez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D. (1995). Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267: 249-252.
41. Serrano M, Hannon GJ, Beach D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707. (Pubitemid 24036021)
42. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37. (Pubitemid 26116804)
43. Shapiro GI, Edwards CD, Ewen ME, Rollins BJ. (1998). p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 18: 378-387. (Pubitemid 28021049)
44. Souza-Rodrigues E, Estanyol JM, Friedrich-Heineken E, Olmedo E, Vera J, Canela N et al. (2007). Proteomic analysis of p16ink4a-binding proteins. Proteomics 7: 4102-4111.
45. Urashima M, DeCaprio JA, Chauhan D, Teoh G, Ogata A, Treon SP et al. (1997). p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. Blood 90: 4106-4115. (Pubitemid 27484066)
46. Vasudevan S, Tong Y, Steitz JA. (2007). Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934.
47. Wang B, David MD, Schrader JW. (2005). Absence of caprin-1 results in defects in cellular proliferation. J Immunol 175: 4274-4282. (Pubitemid 41361961)
48. Wolff B, Naumann M. (1999). INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB. Oncogene 18: 2663-2666. (Pubitemid 29216690)
49. Woods K, Thomson JM, Hammond SM. (2007). Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282: 2130-2134. (Pubitemid 47076737)
50. Yin Q, Wang X, McBride J, Fewell C, Flemington E. (2008). B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 283: 2654-2662.
51. Zhu W, Giangrande PH, Nevins JR. (2004). E2Fs link the control of G1/S and G2/M transcription. Embo J 23: 4615-4626. (Pubitemid 39657861)
52. Zwicker J, Lucibello FC, Wolfraim LA, Gross C, Truss M, Engeland K et al. (1995). Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. Embo J 14: 4514-4522.